REGULATION AGAINST THE COUNTERFEITING OF PHARMACEUTICAL PRODUCTS IN LATIN AMERICA
- REGULATORY FRAMEWORK
- AUTHORITIES
- PASSABLE SUBJECTS OF PENALTY
- TYPE OF SANCTIONS
- FALSIFIED GOODS DESTINATION SEIZED AT THE END OF THE PROCESS
- PRECAUTIONARY MEASURES (MC)
- MEASURES IN BORDER
Attached Files
MASTER_FINAL.pdf
Addendum-Anexo-No-1-Argentina.pdf
Addendum-Anexo-No-2-Belize.pdf
Addendum-Anexo-No-3-Bolivia.pdf
Addendum-Anexo-No-4-Costa-Rica.pdf
Addendum-Anexo-No-5-Brazil.pdf
Addendum-Anexo-No-6-Chile.pdf
Addendum-Anexo-No-7-Colombia.pdf
Addendum-Anexo-No-8-Ecuador.pdf
Addendum-Anexo-No-09-El-Salvador.pdf
Addendum-Anexo-No-10-Guatemala.pdf
Addendum-Anexo-No-11-Honduras.pdf
Addendum-Anexo-No-12-Mexico.pdf
Addendum-Anexo-No-13-Nicaragua.pdf
Addendum-Anexo-No-14-Panama.pdf
Addendum-Anexo-No-15-Paraguay.pdf
Addendum-Anexo-No-16-Peru.pdf
Addendum-Anexo-No-17-Republica-Dominicana.pdf
Addendum-Anexo-No-18-Uruguay.pdf
Addendum-Anexo-No-19-Venezuela.pdf
